Inhibrx Biosciences Stock (NASDAQ: INBX) stock price, news, charts, stock research, profile.
Open | $14.20 |
Close | $13.91 |
Volume / Avg. | 78.16K / 538.22K |
Day Range | 13.54 - 14.47 |
52 Wk Range | 12.61 - 39.79 |
Market Cap | $201.36M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 1.71% |
Days to Cover | 1.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Other companies in Inhibrx Biosciences’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), Opthea (NASDAQ:OPT) and Genfit (NASDAQ:GNFT).
There is no analysis for Inhibrx Biosciences.
Inhibrx Biosciences has a consensus price target of $45.25.
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $13.91 last updated July 17, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Inhibrx Biosciences.
Inhibrx Biosciences’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Inhibrx Biosciences.
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.